Based on DA8600 sequencing platform, we operate 4 reference laboratories domestically, built associated laboratories with over 30 provinces' reproductive centers and conducted business with over 200 domestic medical institutions. In addition, the platform has a wide range of application fields, including: maternity and child health care, genetic disease, tumor personalized treatment, drug metabolism, blood system diseases and infectious diseases.
B
A
S
E
C
A
R
E
Instrument/Diagnosis
High-throughput sequencer
AS one of the first sequencing system approved by CFDA (Approval No.20143221961), DA8600 is specially designed for clinical application and is applicable to various genetic research and services.
Product introduction
High-throughput Sequencer
DA8600 system combines semiconductor sequencing technology with biochemistry to directly translate chemical information into digital data. Chip-based semiconductor sequencing enables you to scale your runs to your research needs.
DA8600 System offers a complete workflow from sample through analysis, and variant calling or RNA analysis. It may be used with the BS1000 System to enable automated, high-throughput template preparation and reproducible chip loading. DA8600 System provides fast sequencing run times, taking you from DNA to variants in a single day. It is equipped with the Ion Reporter Software, providing integrated tools for tertiary data analysis for DNA variation analysis across single, paired, or trio research samples.
Advantages
Fast
Time-saving, with genetic testing done in only 3 hours
Medium-throughput
Reasonable detection cost based on short report cycle
Good compatibility
Simultaneous sequencing for samples of different detections
Good stability
Experienced, more than one million clinical samples were verified
Easy to operate
Maximized flexibility based on the well-designed system
Wide application
Applicable for noninvasive prenatal,tumor and fertility field
Service process
